The Science of Psychedelics: Training for Medical Professionals CME Accreditation (Physicians)

Key Features

• 8 AMA PRA Category 1 Credits™
• Six (6) didactic video modules of 60 to 90 minutes each, including beautiful slides, diagrams of detailed topics, and webcam of the instructor
• Online, on-demand course: learn at your own pace, on your own time
• Video clips and case report summaries from actual patients
• Bibliography with cited publications and links
• Transcriptions and keyword insights for each module
• Links to suggested videos, articles, and other recommended resources
• One (1) bonus module with guided self-reflection and an experiential component
• Assessment quiz for each module
• Evaluation form for each module (for those pursuing CE/CME)
• Access to our online learning platform for after purchase as long as our website exists
• Official Certificate of Completion, CE certificate, or CME certificate upon completion

Topics Covered

• MDMA: Promise in PTSD and Beyond
• Mechanisms of Action: What We Know About the Classic Psychedelics
• Ketamine for Depression and Mood Disorders: Microdoses, Psychedelic Doses, and Everything In Between
• Psychedelic Counseling: The Foundations of Therapeutic ‘Trip Sitting’
• Microdosing Psychedelics: What We Know and Don’t
• The Psychedelic Treatment of Addiction: LSD, Psilocybin, Ayahuasca, Iboga

Learning Objectives

• Recognize which conditions have been shown to respond to MDMA-assisted psychotherapy
• Explain the pharmacological mechanisms of action of MDMA
• Implement and create the ideal office/space environment for MDMA-psychotherapy session
• Advise patients regarding the safety risks, side effects, and contraindications for MDMA-assisted therapy
• Identify the medications and supplements that should not be combined with MDMA
• Describe MDMA’s legal history and its current DEA scheduling
• Discuss the cultural and legal history of psychedelic medicine in the United States
• Evaluate the available safety and efficacy data on the pharmacological mechanisms of action and pharmacokinetics of various “classic” psychedelics
• Summarize some of the recent clinical trials and other research done on each of these substances
• Improve the treatment of mood disorders by differentiating between how psychedelic medicines and conventional anti-depressant medications work on the brain
• Explain the theory of the default mode network and its effects of mood and behavior
• Analyze the elements of the mystical experience and explain their importance in the context of psychological recovery
• Recognize which conditions have been shown to respond to the off-label use of ketamine in recent clinical trials
• Explain the pharmacological differences between S- R- and racemic ketamine
• Summarize which uses of ketamine are currently FDA approved, and for what indications
• Discuss the safety risks, side effects, and contraindications for ketamine
• Incorporate new clinical data on the new routes of administration and dosage protocols by which ketamine may be administered for psychological treatment purposes
• Determine which patients may be good candidates for ketamine treatment
• Summarize the current theory on ketamine’s pharmacological mechanism of action in the treatment of mood disorders
• Explain the common causes of a “bad trip,” and how to prevent them
• Implement proper set and setting in sessions, and describe their importance within the psychotherapeutic context of psychedelic use
• Develop basic strategies in non-directive therapy
• Summarize the theory of Internal Family Systems (IFS) therapy
• Support a patient experiencing a challenging psychedelic experience
• Incorporate “integration” into the healing experience and articulate its importance within the context of psychedelic therapy
• Summarize the challenges and roadblocks of conducting double-blind, placebo-controlled trials on psychedelic microdosing
• Define psychedelic microdosing, and differentiate it from medium or macrodosing
• Evaluate and new and emerging data regarding the theorized mechanism of action of psychedelic microdoses’ effects on mood and behavior
• Discuss the safety risks, side effects, and contraindications for microdosing
• Explain the drug-drug interactions of psychedelic microdoses with common Rx medications
• Identify the patients/conditions that may potentially respond well to psychedelic microdosing
• Evaluate new and emerging therapies to determine how they may be integrated into the treatment of various substance use disorders
• Analyze the elements of the mystical experiences and explain their importance in the context of addiction recovery
• Summarize some of the recent clinical trials and other research done on each of these substances
• List the differences between how psychedelic medicines and conventional medications treat addiction
• Explain the differences between LSD, Psilocybin, Ayahuasca, and Ibogaine with respect to their cultural origins
• Implement protocols for screening for contraindications/cautions in using these substances in the treatment of addiction

Target Audience

Physicians, psychiatrists, psychologists, social workers, mental health counsellors, and pharmacists.

Additional credit info

CME Consultants

D.O. or M.D. credentials will be required for this accreditation.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of CME Consultants and MD Media, Inc. CME Consultants is accredited by the ACCME to provide continuing medical education for physicians.

CME Consultants designates this enduring material for a maximum of 8.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Please read the Activity Disclaimer for important CME information, including disclosure statements, before purchasing this version of the course.

(NOTE FOR CMELIST: CME Consultants require we list the information on this webpage somewhere before the learner purchases the course, if you want that to be a page on the CME site that is fine with us.)